G-401
Resource Report
Resource Website
10+ mentions
Misclassified
|
RRID:CVCL_0270
|
Homo sapiens (Human)
|
Rhabdoid tumor of the kidney
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007; PubMed=30924592)..
|
PMID:8382007 PMID:9671307 PMID:10397258 PMID:10602515 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25877200 PMID:26351324 PMID:27397505 PMID:28945250 PMID:30894373 PMID:30924592 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
G401, G 401 |
|
|
BTO:BTO_0002586, CLO:CLO_0003434, EFO:EFO_0002179, MCCL:MCC:0000161, CLDB:cl1409, 4DN:4DNSR6XERO32, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1441, BCRJ:0418, BioSample:SAMN03470969, BioSample:SAMN03472819, BioSample:SAMN10987919, cancercelllines:CVCL_0270, CCRID:1101HUM-PUMC000034, Cell_Model_Passport:SIDM00856, ChEMBL-Cells:CHEMBL3308394, ChEMBL-Targets:CHEMBL613509, Cosmic:683682, Cosmic:802044, Cosmic:802245, Cosmic:907299, Cosmic-CLP:907299, DepMap:ACH-000096, ECACC:87042204, EGA:EGAS00001000978, ENCODE:ENCBS062JBT, ENCODE:ENCBS432GBV, ENCODE:ENCBS629BMK, ENCODE:ENCBS659PBH, FANTOM5_SSTAR:10809-111A8, GDSC:907299, GEO:GSM827165, GEO:GSM887017, GEO:GSM888086, GEO:GSM1669799, GEO:GSM1676299, GEO:GSM1701634, GEO:GSM2033123, GEO:GSM2033124, GEO:GSM2033125, GEO:GSM2033126, GEO:GSM2033127, GEO:GSM2033128, GEO:GSM2409659, GEO:GSM2409660, GEO:GSM2409661, GEO:GSM2409662, GEO:GSM2409663, GEO:GSM2495985, GEO:GSM2787352, IARC_TP53:21334, IGRhCellID:G401, JCRB:JCRB9065, LiGeA:CCLE_546, LINCS_LDP:LCL-1511, PharmacoDB:G401_374_2019, PRIDE:PXD030304, Progenetix:CVCL_0270, PubChem_Cell_line:CVCL_0270, TOKU-E:1303, Wikidata:Q54835347 |
|
|
CVCL_0270 |
2026-09-12 05:31:22 |
17 |
G-292 clone A141B1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2909
|
Homo sapiens (Human)
|
Osteosarcoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2233717 PMID:20215515 PMID:22460905 PMID:25877200 PMID:27397505 PMID:28196595 PMID:30214690 PMID:30872698 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
G 292 Clone A 141B1, G-292, clone A141B1, G292CLONEA141B1, G-292, G292 |
|
|
BTO:BTO_0003877, CLO:CLO_0003428, CLO:CLO_0009874, EFO:EFO_0022578, CLDB:cl1406, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1423, BCRC:60225, BioGRID_ORCS_Cell_line:674, BioSample:SAMN03470921, BioSample:SAMN10988164, cancercelllines:CVCL_2909, Cell_Model_Passport:SIDM00858, ChEMBL-Cells:CHEMBL3307362, ChEMBL-Targets:CHEMBL614298, Cosmic:931041, Cosmic:931914, Cosmic:1074401, Cosmic:1733127, Cosmic-CLP:1290807, DepMap:ACH-000082, ECACC:90110522, EGA:EGAS00001000978, GDSC:1290807, GEO:GSM320832, GEO:GSM827342, GEO:GSM887015, GEO:GSM888084, GEO:GSM1669797, IARC_TP53:21657, IARC_TP53:30033, JCRB:IFO50107, KCLB:21423, LiGeA:CCLE_486, LINCS_LDP:LCL-1420, NCBI_Iran:C116, PharmacoDB:G292_clone_A141B1_372_2019, PRIDE:PXD030304, Progenetix:CVCL_2909, PubChem_Cell_line:CVCL_2909, Wikidata:Q54835341 |
|
|
CVCL_2909 |
2026-09-12 05:31:22 |
6 |
GA-10
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1222
|
Homo sapiens (Human)
|
Adult Burkitt leukemia
|
Virology: EBV-negative., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:11482875 PMID:20215515 PMID:22460905 PMID:25355872 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
GA10 |
|
|
CLO:CLO_0003439, EFO:EFO_0002181, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2392, BioSample:SAMN03473120, BioSample:SAMN10987941, cancercelllines:CVCL_1222, Cell_Model_Passport:SIDM00854, ChEMBL-Cells:CHEMBL4523538, ChEMBL-Targets:CHEMBL4523569, Cosmic:1303896, Cosmic-CLP:1303896, DepMap:ACH-000162, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1303896, GEO:GSM827343, GEO:GSM887019, GEO:GSM888088, GEO:GSM1669801, IARC_TP53:16698, IGRhCellID:GA10, LiGeA:CCLE_930, LINCS_LDP:LCL-2020, PharmacoDB:GA10_395_2019, PRIDE:PXD030304, Progenetix:CVCL_1222, PubChem_Cell_line:CVCL_1222, Wikidata:Q54835415 |
|
|
CVCL_1222 |
2026-09-12 05:31:24 |
2 |
GaMG
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1226
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3178168 PMID:8239502 PMID:20164919 PMID:22278370 PMID:22460905 PMID:24618588 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
GaMg, GAMG, GA-MG |
|
|
BTO:BTO_0004860, CLO:CLO_0003450, CLDB:cl1441, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:673, BioSample:SAMN03473386, BioSample:SAMN10988278, cancercelllines:CVCL_1226, Cell_Model_Passport:SIDM01055, ChEMBL-Cells:CHEMBL3308734, ChEMBL-Targets:CHEMBL1075447, Cosmic:687567, Cosmic:906868, Cosmic:1175810, Cosmic:1746947, Cosmic:2302330, Cosmic:2367525, Cosmic-CLP:906868, DepMap:ACH-000098, DSMZ:ACC-242, DSMZCellDive:ACC-242, EGA:EGAS00001000978, GDSC:906868, GEO:GSM326237, GEO:GSM887020, GEO:GSM888089, GEO:GSM1669804, GEO:GSM7701389, GEO:GSM7701390, IARC_TP53:21338, LiGeA:CCLE_700, LINCS_LDP:LCL-1351, Lonza:1009, PharmacoDB:GAMG_398_2019, PRIDE:PXD002395, PRIDE:PXD030304, Progenetix:CVCL_1226, PubChem_Cell_line:CVCL_1226, Wikidata:Q54835434 |
|
|
CVCL_1226 |
2026-09-12 05:31:24 |
1 |
GDM-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1230
|
|
|
Derived from sampling site: Peripheral blood., Misspelling: GMD-1; In Cosmic 2131537., Omics: Transcriptome analysis., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep RNAseq analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Microsatellite instability: Stable (MSS) (Sanger)., Doubling time: 96-12 hours (PubMed=6296552); ~40-50 hours (DSMZ)., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6296552 PMID:16408098 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23955599 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Female |
GDM1 |
|
|
CLO:CLO_0003467, EFO:EFO_0002183, CLDB:cl1446, CLDB:cl5541, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2627, BioSample:SAMN03473160, BioSample:SAMN10987916, Cell_Model_Passport:SIDM01057, CGH-DB:9221-4, ChEMBL-Cells:CHEMBL3308198, ChEMBL-Targets:CHEMBL2366157, Cosmic:787430, Cosmic:906870, Cosmic:947368, Cosmic:975249, Cosmic:999777, Cosmic:1012067, Cosmic:1177802, Cosmic:1197932, Cosmic:1281313, Cosmic:2089666, Cosmic:2131537, Cosmic:2306196, Cosmic-CLP:906870, DepMap:ACH-000081, DSMZ:ACC-87, DSMZCellDive:ACC-87, EGA:EGAS00001000978, GDSC:906870, GEO:GSM887023, GEO:GSM888093, GEO:GSM1446735, GEO:GSM1669808, ICLC:HTL01008, IARC_TP53:21342, IGRhCellID:GDM1, LiGeA:CCLE_860, LINCS_LDP:LCL-1052, PharmacoDB:GDM1_402_2019, PRIDE:PXD030304, Progenetix:CVCL_1230, PubChem_Cell_line:CVCL_1230, Wikidata:Q54835529 |
|
|
CVCL_1230 |
2026-09-12 05:31:27 |
5 |
GCT
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1229
|
Homo sapiens (Human)
|
Undifferentiated pleomorphic sarcoma
|
Population: Caucasian., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:304748 PMID:6299509 PMID:7689482 PMID:12068308 PMID:20164919 PMID:20215515 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
Giant Cell Tumor, UR-HCL-1, University of Rochester-Human Cell Line-1 |
|
|
CLO:CLO_0003464, EFO:EFO_0002182, CLDB:cl1445, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:TIB-223, BCRC:60474, BioSample:SAMN03471887, BioSample:SAMN10987909, cancercelllines:CVCL_1229, Cell_Model_Passport:SIDM00853, ChEMBL-Cells:CHEMBL3308471, ChEMBL-Targets:CHEMBL1075448, CLS:300155, Cosmic:684227, Cosmic:906999, Cosmic-CLP:906999, DepMap:ACH-000835, EGA:EGAS00001000978, FANTOM5_SSTAR:10711-109H9, GDSC:906999, GEO:GSM184402, GEO:GSM184403, GEO:GSM827496, GEO:GSM887022, GEO:GSM888092, GEO:GSM1669807, IARC_TP53:21341, IGRhCellID:GCT, IZSLER:BS TCL 94, LiGeA:CCLE_019, LINCS_LDP:LCL-1752, PharmacoDB:GCT_401_2019, PRIDE:PXD030304, Progenetix:CVCL_1229, PubChem_Cell_line:CVCL_1229, Wikidata:Q54835514 |
|
|
CVCL_1229 |
2026-09-12 05:31:27 |
3 |
GCIY
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1228
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Characteristics: Produces AFP (PubMed=11314020)., Population: Japanese., Part of: JFCR45 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1653599 PMID:9290701 PMID:11314020 PMID:15767549 PMID:20164919 PMID:22460905 PMID:24587255 PMID:25984343 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
CLO:CLO_0050793, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:671, BioSample:SAMN03472290, BioSample:SAMN10987813, cancercelllines:CVCL_1228, Cell_Model_Passport:SIDM00274, ChEMBL-Cells:CHEMBL3308825, ChEMBL-Targets:CHEMBL2366234, Cosmic:889110, Cosmic:906869, Cosmic:983729, Cosmic:1001652, Cosmic:1187272, Cosmic-CLP:906869, DepMap:ACH-000047, EGA:EGAS00001000978, GDSC:906869, GEO:GSM887021, GEO:GSM888091, GEO:GSM1669806, IARC_TP53:21340, LiGeA:CCLE_311, LINCS_LDP:LCL-1891, PharmacoDB:GCIY_400_2019, PRIDE:PXD030304, Progenetix:CVCL_1228, PubChem_Cell_line:CVCL_1228, RCB:RCB0555, RCB:RCB1883, TKG:TKG 0405, Wikidata:Q54835507 |
|
|
CVCL_1228 |
2026-09-12 05:31:26 |
6 |
GDM-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1230
|
|
|
Derived from sampling site: Peripheral blood., Misspelling: GMD-1; In Cosmic 2131537., Omics: Transcriptome analysis., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep RNAseq analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Microsatellite instability: Stable (MSS) (Sanger)., Doubling time: 96-12 hours (PubMed=6296552); ~40-50 hours (DSMZ)., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6296552 PMID:16408098 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23955599 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Female |
GDM1 |
|
|
CLO:CLO_0003467, EFO:EFO_0002183, CLDB:cl1446, CLDB:cl5541, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2627, BioSample:SAMN03473160, BioSample:SAMN10987916, Cell_Model_Passport:SIDM01057, CGH-DB:9221-4, ChEMBL-Cells:CHEMBL3308198, ChEMBL-Targets:CHEMBL2366157, Cosmic:787430, Cosmic:906870, Cosmic:947368, Cosmic:975249, Cosmic:999777, Cosmic:1012067, Cosmic:1177802, Cosmic:1197932, Cosmic:1281313, Cosmic:2089666, Cosmic:2131537, Cosmic:2306196, Cosmic-CLP:906870, DepMap:ACH-000081, DSMZ:ACC-87, DSMZCellDive:ACC-87, EGA:EGAS00001000978, GDSC:906870, GEO:GSM887023, GEO:GSM888093, GEO:GSM1446735, GEO:GSM1669808, ICLC:HTL01008, IARC_TP53:21342, IGRhCellID:GDM1, LiGeA:CCLE_860, LINCS_LDP:LCL-1052, PharmacoDB:GDM1_402_2019, PRIDE:PXD030304, Progenetix:CVCL_1230, PubChem_Cell_line:CVCL_1230, Wikidata:Q54835529 |
|
|
CVCL_1230 |
2026-09-12 05:31:27 |
5 |
CA46
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1101
|
Homo sapiens (Human)
|
Burkitt lymphoma
|
Virology: EBV-negative., Characteristics: Produces IgM kappa (ATCC=CRL-1648)., Part of: MYC genetic alteration cell panel (ATCC TCP-1035)., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1325212 PMID:2052620 PMID:3026973 PMID:3080238 PMID:3100061 PMID:3921823 PMID:6243721 PMID:6243722 PMID:6265077 PMID:6286763 PMID:7757991 PMID:8176200 PMID:8220424 PMID:8316623 PMID:8344493 PMID:8402660 PMID:8515068 PMID:8558920 PMID:8568269 PMID:9192833 PMID:9473234 PMID:9563901 PMID:9643977 PMID:9787181 PMID:9973220 PMID:10567774 PMID:11587216 PMID:12145705 PMID:16960149 PMID:17254797 PMID:19220422 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22885699 PMID:24590883 PMID:25355872 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
CA-46, CA 46 |
|
|
BTO:BTO_0000789, CLO:CLO_0002168, EFO:EFO_0002124, CLDB:cl608, CLDB:cl609, CLDB:cl610, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1648, BCRC:60511, BioSample:SAMN03473116, BioSample:SAMN10987878, cancercelllines:CVCL_1101, CCRID:1101HUM-PUMC000366, CCRID:4201HUM-CCTCC00098, CCTCC:GDC0098, Cell_Model_Passport:SIDM00907, ChEMBL-Cells:CHEMBL3308488, ChEMBL-Targets:CHEMBL612566, CLS:305082, Cosmic:687837, Cosmic:850210, Cosmic:910703, Cosmic:931101, Cosmic:1086325, Cosmic:1818340, Cosmic:2297029, Cosmic:2808223, Cosmic:2814536, Cosmic-CLP:910703, DepMap:ACH-000440, DSMZ:ACC-73, DSMZCellDive:ACC-73, ECACC:95010509, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910703, GEO:GSM119505, GEO:GSM886900, GEO:GSM887965, GEO:GSM1177977, GEO:GSM1177978, GEO:GSM1669641, IARC_TP53:7395, ICLC:HTL97007, IGRhCellID:CA46, IZSLER:BS TCL 159, LiGeA:CCLE_534, LINCS_LDP:LCL-2017, Lonza:439, NCBI_Iran:C106, PharmacoDB:CA46_159_2019, PRIDE:PXD030304, Progenetix:CVCL_1101, PubChem_Cell_line:CVCL_1101, Wikidata:Q54808297 |
|
|
CVCL_1101 |
2026-09-12 05:23:00 |
8 |
C8166
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1099
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6412453 PMID:12920029 PMID:20164919 PMID:20215515 PMID:30894373 PMID:31068700
|
Transformed cell line
|
Male |
C8166-CD4 |
|
|
CLO:CLO_0002149, CLDB:cl589, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN10989599, cancercelllines:CVCL_1099, Cell_Model_Passport:SIDM00072, ChEMBL-Cells:CHEMBL3307638, ChEMBL-Targets:CHEMBL614533, Cosmic:906829, DepMap:ACH-000206, ECACC:88051601, EGA:EGAS00001000978, GEO:GSM827337, GEO:GSM1669640, IARC_TP53:21206, KCB:KCB 94019YJ, LINCS_LDP:LCL-1011, PharmacoDB:C8166_157_2019, Progenetix:CVCL_1099, PubChem_Cell_line:CVCL_1099, Wikidata:Q54808257 |
|
|
CVCL_1099 |
2026-09-12 05:22:59 |
184 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ECACC Cat# 93120819, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ECACC |
93120819 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-12 05:23:05 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
IZSLER Cat# BS TCL 8, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
IZSLER |
BS TCL 8 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-12 05:23:05 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
|
|
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-12 05:23:05 |
278 |
CAL-148
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1106
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7531416 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
CAL 148, CAL148, Centre Antoine Lacassagne-148 |
|
|
CLO:CLO_0002181, EFO:EFO_0005357, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471761, BioSample:SAMN10988460, cancercelllines:CVCL_1106, Cell_Model_Passport:SIDM00938, ChEMBL-Cells:CHEMBL3308794, ChEMBL-Targets:CHEMBL1075407, Cosmic:924106, Cosmic:1603194, Cosmic:2164985, Cosmic-CLP:924106, DepMap:ACH-000902, DSMZ:ACC-460, DSMZCellDive:ACC-460, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:924106, GEO:GSM274695, GEO:GSM344383, GEO:GSM344433, GEO:GSM783978, GEO:GSM827186, GEO:GSM886906, GEO:GSM887971, GEO:GSM1172945, GEO:GSM1669647, IARC_TP53:27145, LiGeA:CCLE_805, LINCS_HMS:51111, LINCS_LDP:LCL-1464, PharmacoDB:CAL148_167_2019, PRIDE:PXD030304, Progenetix:CVCL_1106, PubChem_Cell_line:CVCL_1106, Wikidata:Q54808386 |
|
|
CVCL_1106 |
2026-09-12 05:23:06 |
6 |
Caki-1
Resource Report
Resource Website
500+ mentions
Discontinued Discontinued Possibly Discontinued
|
RRID:CVCL_0234
|
Homo sapiens (Human)
|
Clear cell renal cell carcinoma
|
Virology: Susceptible to infection by human coronavirus 229E (HCoV-229E), Middle East respiratory syndrome-related coronavirus (MERS-CoV), influenza A virus and respiratory syncytial virus (RSV) (PubMed=37668370)., Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=37668370)., Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:571047 PMID:833871 PMID:2041050 PMID:3335022 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7017212 PMID:7459858 PMID:7591954 PMID:9290701 PMID:9331090 PMID:10700174 PMID:10723130 PMID:10929426 PMID:11146448 PMID:15604581 PMID:15748285 PMID:17088437 PMID:17212712 PMID:17804913 PMID:19372543 PMID:20164919 PMID:20215515 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:22949125 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24477694 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27377824 PMID:27397505 PMID:27807467 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30260228 PMID:30894373 PMID:31068700 PMID:31733513 PMID:31978347 PMID:35839778 PMID:37668370 PMID:38861359
|
Cancer cell line
|
Male |
CAKI-1, CaKi-1, caki-1, CAKI.1, CAKI 1, CAKI1, Caki1 |
|
|
BTO:BTO_0003204, CLO:CLO_0002175, CLO:CLO_0002176, EFO:EFO_0002149, MCCL:MCC:0000123, CLDB:cl623, CLDB:cl5175, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-46, BioGRID_ORCS_Cell_line:582, BioSample:SAMN01821541, BioSample:SAMN01821674, BioSample:SAMN03473223, BioSample:SAMN10987640, cancercelllines:CVCL_0234, CancerTools:161903, CCRID:1101HUM-PUMC000244, CCRID:3101HUMSCSP5064, CCRID:3101HUMTCHu135, Cell_Model_Passport:SIDM00941, ChEMBL-Cells:CHEMBL3307522, ChEMBL-Targets:CHEMBL614067, CLS:300149, Cosmic:687940, Cosmic:801356, Cosmic:849379, Cosmic:874611, Cosmic:875871, Cosmic:897463, Cosmic:905963, Cosmic:974303, Cosmic:979705, Cosmic:1044261, Cosmic:1092594, Cosmic:1305375, Cosmic:1312363, Cosmic:1998436, Cosmic:2036675, Cosmic:2301558, Cosmic:2520632, Cosmic-CLP:905963, DepMap:ACH-000433, DSMZ:ACC-142, DSMZ:ACC-731, DSMZCellDive:ACC-731, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:905963, GEO:GSM2147, GEO:GSM50229, GEO:GSM50293, GEO:GSM743483, GEO:GSM750816, GEO:GSM799374, GEO:GSM799437, GEO:GSM846288, GEO:GSM886902, GEO:GSM887967, GEO:GSM1153447, GEO:GSM1177994, GEO:GSM1177995, GEO:GSM1181288, GEO:GSM1181368, GEO:GSM1669644, GEO:GSM2124663, IARC_TP53:21041, IGRhCellID:Caki1, IPD-IMGT/HLA:13865, IZSLER:BS TCL 108, JCRB:JCRB0801, KCB:KCB 200850YJ, KCLB:30046, LiGeA:CCLE_484, LINCS_LDP:LCL-1774, MetaboLights:MTBLS737, NCI-DTP:CAKI-1, PharmacoDB:CAKI1_163_2019, PRIDE:PXD003105, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_0234, PubChem_Cell_line:CVCL_0234, RCB:RCB1985, SKY/M-FISH/CGH:2790, TKG:TKG 0436, Wikidata:Q54808374 |
|
|
CVCL_0234 |
2026-09-12 05:23:05 |
934 |
CAL-33
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1108
|
Homo sapiens (Human)
|
Tongue squamous cell carcinoma
|
Population: Caucasian., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2145926 PMID:2440566 PMID:3181269 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24710094 PMID:25275298 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34339474 PMID:35839778 PMID:36912284
|
Cancer cell line
|
Male |
Cal-33, CAL 33, CAL33, CAL-SCC-33, Centre Antoine Lacassagne-33 |
|
|
BTO:BTO_0000941, CLO:CLO_0002183, EFO:EFO_0022592, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:841, BioSample:SAMN03473547, BioSample:SAMN10988048, cancercelllines:CVCL_1108, Cell_Model_Passport:SIDM00942, ChEMBL-Cells:CHEMBL3308715, ChEMBL-Targets:CHEMBL1075409, CLS:305496, Cosmic:753541, Cosmic:2296293, Cosmic-CLP:753541, DepMap:ACH-000518, DSMZ:ACC-447, DSMZCellDive:ACC-447, EGA:EGAS00001000978, GDSC:753541, GEO:GSM887974, GEO:GSM1669650, IARC_TP53:21210, LiGeA:CCLE_328, LINCS_LDP:LCL-1216, PharmacoDB:CAL33_170_2019, PRIDE:PXD030304, Progenetix:CVCL_1108, PubChem_Cell_line:CVCL_1108, Wikidata:Q54808398 |
|
|
CVCL_1108 |
2026-09-12 05:23:06 |
32 |
Calu-3
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0609
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474)., Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:3129183 PMID:3335022 PMID:3518877 PMID:3940644 PMID:6220172 PMID:7459858 PMID:7515578 PMID:9636188 PMID:10523844 PMID:11064206 PMID:15463957 PMID:17483357 PMID:18083107 PMID:19153074 PMID:19472407 PMID:20090954 PMID:20164919 PMID:20215515 PMID:20557307 PMID:22460905 PMID:22961666 PMID:24207061 PMID:25485619 PMID:25555374 PMID:25877200 PMID:25894527 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29681454 PMID:30894373 PMID:31068700 PMID:34339474 PMID:35839778 PMID:35879413
|
Cancer cell line
|
Male |
CaLu-3, CALU-3, Calu 3, Calu3, CALU3 |
|
|
BTO:BTO_0002750, CLO:CLO_0002192, EFO:EFO_0002819, CLDB:cl634, CLDB:cl635, CLDB:cl5176, Abcam:ab275465, AddexBio:C0016001/30, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-55, BCRJ:0264, BioGRID_ORCS_Cell_line:1375, BioSample:SAMN03471552, BioSample:SAMN10988517, cancercelllines:CVCL_0609, CancerTools:161906, CCRID:1101HUM-PUMC000032, CCRID:1101HUM-PUMC000329, CCRID:3101HUMTCHu157, CCRID:4201HUM-CCTCC00647, Cell_Model_Passport:SIDM00922, ChEMBL-Cells:CHEMBL3307390, ChEMBL-Targets:CHEMBL614534, CLS:305032, Cosmic:687777, Cosmic:910562, Cosmic:933578, Cosmic:945227, Cosmic:961842, Cosmic:1006532, Cosmic:1028940, Cosmic:1146873, Cosmic:1219068, Cosmic:1239869, Cosmic:1434969, Cosmic:1802295, Cosmic:2125219, Cosmic:2664117, Cosmic:2772161, Cosmic-CLP:687777, DepMap:ACH-000392, EGA:EGAS00001000610, EGA:EGAS00001002554, GDSC:687777, GEO:GSM108803, GEO:GSM108804, GEO:GSM159355, GEO:GSM159356, GEO:GSM159357, GEO:GSM159358, GEO:GSM253347, GEO:GSM353233, GEO:GSM434276, GEO:GSM513948, GEO:GSM514318, GEO:GSM784249, GEO:GSM794262, GEO:GSM817064, GEO:GSM827549, GEO:GSM886915, GEO:GSM887981, GEO:GSM1374433, GEO:GSM1374434, GEO:GSM1669658, IARC_TP53:21264, IGRhCellID:Calu3, IZSLER:BS TCL 103, KCB:KCB 202003YJ, KCLB:30055, LiGeA:CCLE_462, LINCS_HMS:50010, LINCS_LDP:LCL-1631, Lonza:342, MetaboLights:MTBLS762, MetaboLights:MTBLS2352, MetaboLights:MTBLS2840, Millipore:SCC438, PharmacoDB:Calu3_179_2019, PRIDE:PRD000594, PRIDE:PXD000589, PRIDE:PXD019645, PRIDE:PXD023418, PRIDE:PXD023422, PRIDE:PXD023760, PRIDE:PXD024242, PRIDE:PXD024375, PRIDE:PXD024883, PRIDE:PXD025499, PRIDE:PXD026302, PRIDE:PXD030304, PRIDE:PXD034135, Progenetix:CVCL_0609, PubChem_Cell_line:CVCL_0609, TOKU-E:768, Wikidata:Q52392355 |
|
|
CVCL_0609 |
2026-09-12 05:23:07 |
1642 |
Capan-2
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0026
|
Homo sapiens (Human)
|
Pancreatic ductal adenocarcinoma
|
Caution: TP53 mutation indicated incorrectly as being at c.818G>A in PubMed=1630814., Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: NCI RAS program mutant KRAS cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1630814 PMID:1764370 PMID:3019537 PMID:3518877 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7809022 PMID:7961102 PMID:7972006 PMID:8026879 PMID:8194712 PMID:8286197 PMID:8426738 PMID:10027410 PMID:11169957 PMID:11169959 PMID:11668190 PMID:12692724 PMID:12800145 PMID:14695172 PMID:15126341 PMID:15367885 PMID:15688027 PMID:15770730 PMID:16957166 PMID:18298655 PMID:18380791 PMID:20037478 PMID:20164919 PMID:20215515 PMID:20418756 PMID:22460905 PMID:22585861 PMID:24700732 PMID:25167228 PMID:25485619 PMID:25877200 PMID:26216984 PMID:26589293 PMID:27259358 PMID:27397505 PMID:30894373 PMID:31037374 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
CaPan-2, CAPAN-2, Capan 2, CAPAN 2, Capan2, CAPAN2 |
|
|
BTO:BTO_0002745, CLO:CLO_0002198, EFO:EFO_0002154, MCCL:MCC:0000127, CLDB:cl642, CLDB:cl643, CLDB:cl644, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-80, BCRJ:0060, BioSample:SAMN03472025, BioSample:SAMN03473387, BioSample:SAMN10988212, cancercelllines:CVCL_0026, CancerTools:161908, Cell_Model_Passport:SIDM00943, CGH-DB:163-1, CGH-DB:9270-4, ChEMBL-Cells:CHEMBL3308720, ChEMBL-Targets:CHEMBL1075417, CLS:300144, Cosmic:730527, Cosmic:736271, Cosmic:755303, Cosmic:808163, Cosmic:868246, Cosmic:910915, Cosmic:913303, Cosmic:922256, Cosmic:923167, Cosmic:932517, Cosmic:932987, Cosmic:933522, Cosmic:934554, Cosmic:947396, Cosmic:948727, Cosmic:949232, Cosmic:1006366, Cosmic:1108339, Cosmic:1299297, Cosmic:1320463, Cosmic:1366277, Cosmic:1571775, Cosmic:1995363, Cosmic:2009527, Cosmic:2046535, Cosmic:2434087, Cosmic:2668288, Cosmic-CLP:910915, DepMap:ACH-000107, DSMZ:ACC-245, DSMZCellDive:ACC-245, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910915, GEO:GSM206453, GEO:GSM621896, GEO:GSM784710, GEO:GSM886921, GEO:GSM887987, GEO:GSM1024399, GEO:GSM1374440, GEO:GSM1669664, GEO:GSM7701427, GEO:GSM7701428, IARC_TP53:313, IARC_TP53:21042, IARC_TP53:30199, IGRhCellID:Capan2, IZSLER:BS TCL 10, KCLB:30080, LiGeA:CCLE_178, LINCS_LDP:LCL-1733, Lonza:1464, MetaboLights:MTBLS812, PharmacoDB:Capan2_185_2019, PRIDE:PXD003198, PRIDE:PXD030304, Progenetix:CVCL_0026, PubChem_Cell_line:CVCL_0026, SKY/M-FISH/CGH:1993, Wikidata:Q54808591 |
|
|
CVCL_0026 |
2026-09-12 05:23:10 |
298 |
CAS-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1117
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:12635657 PMID:20164919 PMID:22460905 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAS1 |
|
|
CLO:CLO_0002200, CLDB:cl4963, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:589, BioSample:SAMN10987869, cancercelllines:CVCL_1117, Cell_Model_Passport:SIDM00212, ChEMBL-Cells:CHEMBL3308187, ChEMBL-Targets:CHEMBL2366100, Cosmic:910943, Cosmic:2367510, Cosmic:2516014, Cosmic-CLP:910943, DepMap:ACH-000464, EGA:EGAS00001000978, GDSC:910943, GEO:GSM886922, GEO:GSM887988, GEO:GSM1669666, IARC_TP53:21216, ICLC:HTL97009, LiGeA:CCLE_412, LINCS_LDP:LCL-1369, PharmacoDB:CAS1_187_2019, PRIDE:PXD030304, Progenetix:CVCL_1117, PubChem_Cell_line:CVCL_1117, Wikidata:Q54808612 |
|
|
CVCL_1117 |
2026-09-12 05:23:11 |
2 |
C32 [Human melanoma]
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1097
|
Homo sapiens (Human)
|
Amelanotic melanoma
|
Population: Caucasian., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: MET genetic alteration cell panel (ATCC TCP-1036)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3182330 PMID:3900210 PMID:9354451 PMID:12068308 PMID:15048078 PMID:15467732 PMID:17363583 PMID:17516929 PMID:20164919 PMID:20215515 PMID:22383533 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25960936 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
C-32, C32-mel, C32 mel, C32r |
|
|
CLO:CLO_0002113, EFO:EFO_0006364, CLDB:cl566, CLDB:cl5173, AddexBio:C0020002/443, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1585, BCRC:60081, BioGRID_ORCS_Cell_line:581, BioSample:SAMN03472821, BioSample:SAMN10988316, cancercelllines:CVCL_1097, Cell_Model_Passport:SIDM00890, CGH-DB:9321-4, ChEMBL-Cells:CHEMBL3308713, ChEMBL-Targets:CHEMBL1075401, Cosmic:687432, Cosmic:888988, Cosmic:905234, Cosmic:906830, Cosmic:928725, Cosmic:933006, Cosmic:1022272, Cosmic:1155267, Cosmic:1458960, Cosmic:1995352, Cosmic-CLP:906830, DepMap:ACH-000580, ECACC:87090201, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906830, GEO:GSM162931, GEO:GSM206449, GEO:GSM215721, GEO:GSM827471, GEO:GSM886898, GEO:GSM887963, GEO:GSM1138788, GEO:GSM1669636, IARC_TP53:21204, IZSLER:BS TCL 150, LiGeA:CCLE_275, LINCS_HMS:50112, LINCS_LDP:LCL-1238, PharmacoDB:C32_154_2019, PRIDE:PXD030304, Progenetix:CVCL_1097, PubChem_Cell_line:CVCL_1097, Wikidata:Q27902869 |
|
|
CVCL_1097 |
2026-09-12 05:22:55 |
12 |